MTOR and neoplasm: Additionally, in tumours subjected to PI3K/mTOR inhibitors, alone or in combination with anti‐PD‐1 therapy, we observed the repolarisation of macrophages towards an anti‐tumourigenic (M1‐like) phenotype.